P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo

Keith E. Norman(Novartis (Switzerland)), Andreas Katopodis(Novartis (Switzerland)), Gebhard Thoma(Novartis (Switzerland)), Frank Kolbinger(Novartis (Switzerland)), Anne E.R. Hicks(Novartis (Switzerland)), Matthew J. Cotter(Novartis (Switzerland)), A. Graham Pockley(Novartis (Switzerland)), Paul G. Hellewell(Novartis (Switzerland))
Blood
November 15, 2000
Cited by 114

Abstract

Selectin-dependent rolling is the earliest observable event in the recruitment of leukocytes to inflamed tissues. Several glycoproteins decorated with sialic acid, fucose, and/or sulfate have been shown to bind the selectins. The best-characterized selectin ligand is P-selectin glycoprotein-1 (PSGL-1) that supports P-selectin- dependent rolling in vitro and in vivo. In vitro studies have suggested that PSGL-1 may also be a ligand for E- and L-selectins. To study the in vivo function of PSGL-1, without the influence of other leukocyte proteins, the authors observed the interaction of PSGL-1-coated microspheres in mouse venules stimulated to express P- and/or E-selectin. Microspheres coated with functional recombinant PSGL-1 rolled in surgically stimulated and tumor necrosis factor alpha (TNFalpha)-stimulated mouse venules. P-selectin deficiency or inhibition abolished microsphere rolling in surgically and TNFalpha-stimulated venules, whereas E-selectin deficiency or inhibition increased microsphere rolling velocity in TNFalpha-stimulated venules. The results suggest that P-selectin-PSGL-1 interaction alone is sufficient to mediate rolling in vivo and that E-selectin-PSGL-1 interaction supports slow rolling.


Related Papers

No related papers found

Powered by citation graph analysis